Abiopharma

Apollo Group OÜ muudab tehnilistel põhjustel võlakirjade tingimusi

Apollo Group OÜ to amend bond terms due to technical adjustment

Results of institutional tender

AVAV DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds AeroVironment (AVAV) Investors of Securities Class Action Deadline on July 27, 2026

UWMC Issues Statement Regarding Second Failure of Two Harbors to Obtain Approval for CCM Transaction

Presentation for the capital market

Samsara Sweeps Fleet Technology Rankings With 23 No. 1 Rankings Across Reports

Digital Turbine to Participate in The Bank of America Global Technology Conference

Cadence and Samsung Foundry Deepen 2nm and 3D‑IC Collaboration to Meet Surging AI Infrastructure and Physical AI Demand

Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care